Valid Ghana · FDA Ghana

CLANZA S SOFT CAPSULES (Each capsule contains Accelotenac 100mg)

Accelotenac

FDA/SD.265-050546 Accelotenac 300mg

What it does

Accelotenac is a medication used to relieve pain and reduce inflammation.

Commonly used for: pain relief, inflammation reduction

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.265-050546
Registration date
2026-12-18
Expiry date
2031-06-01
Status
Valid
Active ingredient
Accelotenac
Dosage form
Accelotenac
Strength
300mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Korea United Pharm
Country of origin
KOREA
Manufacturer location
22 Nonhyeon-ro 121-gil, Gangnam District, Seoul, South Korea

Source: Food and Drugs Authority · fetched 2026-05-22 02:34:50 · updated 2026-10-20 04:00:09

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Accelotenac is a medication used to relieve pain and reduce inflammation.

What it treats

  • pain relief
  • inflammation reduction

How it works

It works by blocking substances in the body that cause pain and swelling.

Who it's for

It is suitable for adults and children who need help managing pain or inflammation.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: accelotenac

Accelotenac is a non-steroidal anti-inflammatory drug (NSAID) used primarily for the management of pain and inflammation. It is often indicated in conditions such as osteoarthritis, rheumatoid arthritis, and acute pain. Like other NSAIDs, it works by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), which play a key role in the synthesis of prostaglandins that mediate pain and inflammatory responses.

Indications

  • Osteoarthritis
  • Rheumatoid arthritis
  • Acute pain
  • Musculoskeletal disorders
  • Post-operative pain management

Dosage

Children: Refer to the BNF for Children for appropriate dosing in children based on age, weight, and the condition being treated.

Adults: Refer to the specific clinical guidelines or BNF for appropriate dosing based on the condition being treated.

Mechanism of action

Accelotenac exerts its therapeutic effects by inhibiting the activity of cyclooxygenase enzymes (COX-1 and COX-2), leading to a decrease in the production of prostaglandins. This results in reduced inflammation, analgesia, and antipyretic effects.

Pharmacodynamics

The pharmacodynamic effects of accelotenac are primarily due to its ability to reduce pain and inflammation. By lowering prostaglandin levels, it decreases the sensitivity of pain receptors and inhibits the inflammatory response. This NSAID provides symptomatic relief in various painful conditions, improving patient mobility and quality of life.

Pharmacokinetics

Accelotenac is well-absorbed after oral administration, with peak plasma concentrations typically occurring within 1 to 2 hours. It is extensively metabolized in the liver, primarily through conjugation, and has a relatively short half-life. The elimination of the drug occurs primarily through the kidneys. Dose adjustments may be necessary in patients with renal impairment.

Contra-indications

  • Hypersensitivity to accelotenac or any component of the formulation
  • Active peptic ulcer disease
  • Severe heart failure
  • History of gastrointestinal bleeding or perforation related to previous NSAID therapy
  • Severe hepatic impairment
  • Severe renal impairment

Adverse effects

  • Gastrointestinal disturbances such as nausea, vomiting, and diarrhea
  • Dyspepsia
  • Abdominal pain
  • Headache
  • Dizziness
  • Rash or pruritus
  • Edema
  • Increased blood pressure
  • Renal toxicity including acute kidney injury

Interactions

  • Increased risk of gastrointestinal bleeding when used with other NSAIDs or anticoagulants
  • May reduce the antihypertensive effect of ACE inhibitors and diuretics
  • Increased risk of nephrotoxicity with concurrent use of other nephrotoxic drugs
  • May enhance the effects of anticoagulants like warfarin

Precautions

  • Use with caution in patients with a history of cardiovascular disease
  • Monitor renal function in patients with renal impairment or those on diuretics
  • Assess for signs of gastrointestinal bleeding, especially in elderly patients
  • Caution in patients with asthma, as NSAIDs may exacerbate symptoms

Pregnancy

Use during pregnancy, particularly in the third trimester, is not recommended due to potential risks to the fetus, including cardiovascular and renal issues.

Breast-feeding

Limited data is available; use with caution and assess risk-benefit.

Storage

Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Formulations

  • Oral tablets
  • Topical gel

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.